血液透析市場レポート：分野、モダリティ、エンドユーザー、地域別、2024～2032年

世界の血液透析市場規模は2023年に907億米ドルに達しました。今後、IMARC Groupは、2024～2032年にかけて3.7%の成長率（CAGR）を示し、2032年までに1,267億米ドルに達すると予測しています。医療プロバイダーと透析メーカー間の協力関係の増加により、治療の利用可能性が促進されていること、高血圧に関連する腎臓病の有病率の上昇、臓器の利用可能性の制限、腎臓病に対する意識の高まり、透析アクセス改善の提唱などが、市場を推進している要因の一部です。

血液透析は、進行した腎臓病や腎不全の患者を治療するための救命医療処置です。血液透析は、腎臓がこれらの機能を効果的に果たせなくなった場合に、血液から老廃物、余分な水分、電解質を除去するためにダイアライザーと呼ばれる専用の機械を使用します。血液透析では、患者さんの血液を血管アクセスポイント（通常は外科的に造られた瘻孔または移植片）を通してダイアライザーに送ります。血液はダイアライザー内の半透膜で濾過され、老廃物や余分な物質が血液から透析液に排出されます。濾過された血液は、患者さんの体内に戻されます。血液透析のセッションは通常数時間で、一般に週に複数回行われます。頻度と期間は、患者さん固有の病状と医療プロバイダーのアドバイスによります。血液透析は、体内の水分と電解質のバランスを維持し、血圧を効果的に管理し、重大な健康合併症を引き起こす有害な老廃物の蓄積を防ぐという重要な役割を担っています。血液透析は要求が高く、多くの場合生涯にわたる治療であるが、腎不全患者の生活の質と寿命を著しく向上させる。

世界市場の主要原動力は、慢性腎臓病の罹患率の増加です。これに伴い、高齢化人口の増加により腎臓に関連する問題が発生しやすくなり、血液透析の必要性が高まっています。さらに、世界の糖尿病の流行は腎臓病患者に大きく寄与し、血液透析を必要とします。これとは別に、肥満に関連した腎臓病が血液透析治療の需要を煽っています。さらに、医療施設へのアクセスが向上したことで、腎臓病の診断と治療が増加しています。透析装置や透析方法の技術革新は、治療効率を向上させています。さらに、腎臓の健康に対する意識の高まりが、早期介入と透析を促しています。さらに、有利な償還政策により、患者は血液透析治療を受けることができます。

血液透析市場の動向と促進要因

医療ツーリズムの増加

医療ツーリズムの動向が市場を刺激しています。高度な医療施設を持ち、治療費が安い国は、質の高い血液透析サービスを求める患者を惹きつけています。医療観光客は、血液透析を含む専門的な医療を、自国にいる場合の何分の一かの費用で受けられる地域を選ぶことが多いです。このような外国人患者の流入により、彼らのニーズに応えるための設備の整った透析センターの設立が必要となります。医療ツーリズムの中心地の医療プロバイダーは、透析能力を拡大し、熟練した専門家を雇用し、需要の増加に対応するために高度な技術を採用しています。医療ツーリズムが増加し続ける中、自宅を離れて治療を求める患者の増加により、市場は成長を遂げています。

世界の透析センターの拡大

透析センターの世界の拡大は、市場を推進する上で極めて重要です。より多くの透析施設がさまざまな地域に設立されることで、血液透析治療へのアクセスがより広まる。これらの透析センターは、腎臓病患者が生命を維持するための血液透析を便利かつタイムリーに受けられるようにします。透析センターのネットワーク拡大は、患者数の増加に対応するだけでなく、早期の診断と介入を促進します。このような拡大は、定期的な血液透析を必要とする患者にとって、よりアクセスしやすく患者中心の環境を作り出すことにより、市場の成長を促進します。さらに、幅広い透析センターが存在することで競争が促進され、それが技術の進歩やサービスの向上を促し、提供される医療全体の質を高め、血液透析サービスの需要を促進しています。

腎臓専門医の不足

腎臓専門医の不足が市場を強化しています。腎臓病患者の増加に対応できる腎臓専門医の数が減少しているため、血液透析サービスの需要が増加しています。この不足に対処するため、医療プロバイダーは血液透析サービスを拡大し、新しいセンターを開設して治療能力を高めています。この現象はまた、遠隔医療ソリューションの開発と導入を促し、血液透析患者の遠隔診察とモニタリングを可能にします。さらに、医療不足は、腎臓内科治療のギャップに対処するため、医療従事者のトレーニングやスキルアッププログラムへの投資を医療機関に促しています。腎臓専門医不足に対処するためのこのような協力的な取り組みにより、血液透析治療がより広く利用できるようになり、最終的には、より多くの患者が腎臓の健康を効果的に管理するためにこれらのサービスを利用するようになり、市場の成長を促進することになります。

目次

第1章 序文

第2章 調査範囲と調査手法

• 調査目的
• 利害関係者
• データソース
  • 一次情報
  • 二次情報
• 市場推定
  • ボトムアップアプローチ
  • トップダウンアプローチ
• 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

• 概要
• 主要産業動向

第5章 血液透析の世界市場

• 市場概要
• 市場実績
• COVID-19の影響
• 市場内訳：分野別
  • 市場内訳：製品別
  • 市場内訳：サービス別
• 市場内訳：モダリティ別
• 市場内訳：エンドユーザー別
• 市場内訳：地域別
• 市場予測

第6章 市場内訳：分野別

• 血液透析製品
  • 市場動向
  • 市場内訳：製品別
    • 機械
    • ダイアライザー
    • その他
  • 市場予測
• 血液透析サービス
  • 市場動向
  • 市場内訳：サービス別
    • センター内サービス
    • 在宅サービス
  • 市場予測

第7章 市場内訳：モダリティ別

• 従来型血液透析
• 短時間日次血液透析
• 夜間血液透析

第8章 市場内訳：エンドユーザー別

• 病院
• 独立系透析センター
• その他

第9章 市場内訳：地域別

• アジア太平洋
• 欧州
• 北米
• 中東・アフリカ
• ラテンアメリカ

第10章 SWOT分析

• 概要
• 強み
• 弱み
• 機会
• 脅威

第11章 バリューチェーン分析

第12章 ポーターのファイブフォース分析

• 概要
• 買い手の交渉力
• 供給企業の交渉力
• 競合の程度
• 新規参入業者の脅威
• 代替品の脅威

第13章 競合情勢

• 市場構造
• 主要企業
• 主要企業のプロファイル
  • Baxter International
  • Asahi Kasei Corporation
  • B. Barun Melsungen
  • DaVita
  • Cantel Medical Corporation
  • Fresenius Medical Care
  • Nipro Corporation
  • Rockwell Medical
  • Medivators
  • Toray Medical Company Ltd.
  • Nikkiso Co. Ltd.
  • Surni Group
  • Gambro
  • Satellite Healthcare Inc.
  • Renacon Pharma Ltd.

List of Figures

• Figure 1: Global: Hemodialysis Market: Major Drivers and Challenges
• Figure 2: Global: Hemodialysis Market: Sales Value (in Billion US$), 2018-2023
• Figure 3: Global: Hemodialysis Market: Breakup by Segment (in %), 2023
• Figure 4: Global: Hemodialysis Market: Breakup by Product (in %), 2023
• Figure 5: Global: Hemodialysis Market: Breakup by Service (in %), 2023
• Figure 6: Global: Hemodialysis Market: Breakup by Modality (in %), 2023
• Figure 7: Global: Hemodialysis Market: Breakup by End-User (in %), 2023
• Figure 8: Global: Hemodialysis Market: Breakup by Region (in %), 2023
• Figure 9: Global: Hemodialysis Market Forecast: Sales Value (in Billion US$), 2024-2032
• Figure 10: Global: Hemodialysis Industry: SWOT Analysis
• Figure 11: Global: Hemodialysis Industry: Value Chain Analysis
• Figure 12: Global: Hemodialysis Industry: Porter's Five Forces Analysis
• Figure 13: Global: Hemodialysis (Hemodialysis Product) Market: Sales Value (in Billion US$), 2018 & 2023
• Figure 14: Global: Hemodialysis (Hemodialysis Product) Market Forecast: Sales Value (in Billion US$), 2024-2032
• Figure 15: Global: Hemodialysis (Hemodialysis Service) Market: Sales Value (in Billion US$), 2018 & 2023
• Figure 16: Global: Hemodialysis (Hemodialysis Service) Market Forecast: Sales Value (in Billion US$), 2024-2032
• Figure 17: Global: Hemodialysis (Conventional Hemodialysis) Market: Sales Value (in Billion US$), 2018 & 2023
• Figure 18: Global: Hemodialysis (Conventional Hemodialysis) Market Forecast: Sales Value (in Billion US$), 2024-2032
• Figure 19: Global: Hemodialysis (Short Daily Hemodialysis) Market: Sales Value (in Billion US$), 2018 & 2023
• Figure 20: Global: Hemodialysis (Short Daily Hemodialysis) Market Forecast: Sales Value (in Billion US$), 2024-2032
• Figure 21: Global: Hemodialysis (Nocturnal Hemodialysis) Market: Sales Value (in Billion US$), 2018 & 2023
• Figure 22: Global: Hemodialysis (Nocturnal Hemodialysis) Market Forecast: Sales Value (in Billion US$), 2024-2032
• Figure 23: Global: Hemodialysis (Hospitals) Market: Sales Value (in Billion US$), 2018 & 2023
• Figure 24: Global: Hemodialysis (Hospitals) Market Forecast: Sales Value (in Billion US$), 2024-2032
• Figure 25: Global: Hemodialysis (Independent Dialysis Centres) Market: Sales Value (in Billion US$), 2018 & 2023
• Figure 26: Global: Hemodialysis (Independent Dialysis Centres) Market Forecast: Sales Value (in Billion US$), 2024-2032
• Figure 27: Global: Hemodialysis (Other End-Users) Market: Sales Value (in Billion US$), 2018 & 2023
• Figure 28: Global: Hemodialysis (Other End-Users) Market Forecast: Sales Value (in Billion US$), 2024-2032
• Figure 29: Asia Pacific: Hemodialysis Market: Sales Value (in Billion US$), 2018 & 2023
• Figure 30: Asia Pacific: Hemodialysis Market Forecast: Sales Value (in Billion US$), 2024-2032
• Figure 31: Europe: Hemodialysis Market: Sales Value (in Billion US$), 2018 & 2023
• Figure 32: Europe: Hemodialysis Market Forecast: Sales Value (in Billion US$), 2024-2032
• Figure 33: North America: Hemodialysis Market: Sales Value (in Billion US$), 2018 & 2023
• Figure 34: North America: Hemodialysis Market Forecast: Sales Value (in Billion US$), 2024-2032
• Figure 35: Middle East and Africa: Hemodialysis Market: Sales Value (in Billion US$), 2018 & 2023
• Figure 36: Middle East and Africa: Hemodialysis Market Forecast: Sales Value (in Billion US$), 2024-2032
• Figure 37: Latin America: Hemodialysis Market: Sales Value (in Billion US$), 2018 & 2023
• Figure 38: Latin America: Hemodialysis Market Forecast: Sales Value (in Billion US$), 2024-2032

List of Tables

• Table 1: Global: Hemodialysis Market: Key Industry Highlights, 2023 and 2032
• Table 2: Global: Hemodialysis Market Forecast: Breakup by Segment (in Billion US$), 2024-2032
• Table 3: Global: Hemodialysis Market Forecast: Breakup by Modality (in Billion US$), 2024-2032
• Table 4: Global: Hemodialysis Market Forecast: Breakup by End-User (in Billion US$), 2024-2032
• Table 5: Global: Hemodialysis Market Forecast: Breakup by Region (in Billion US$), 2024-2032
• Table 6: Global: Hemodialysis Market Structure
• Table 7: Global: Hemodialysis Market: Key Players

The global hemodialysis market size reached US$ 90.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 126.7 Billion by 2032, exhibiting a growth rate (CAGR) of 3.7% during 2024-2032. The increasing collaborations between healthcare providers and dialysis manufacturers promote treatment availability, the rising prevalence of hypertension-related kidney diseases, the limited organ availability, the growing awareness about kidney diseases, and advocacy for improved dialysis access are some of the factors propelling the market.

Hemodialysis is a life-saving medical procedure for treating individuals with advanced kidney disease or kidney failure. It involves using a specialized machine called a dialyzer to remove waste, excess fluids, and electrolytes from the blood when the kidneys can no longer perform these functions effectively. During hemodialysis, a patient's blood is diverted from their body through a vascular access point (usually a surgically created fistula or graft) to the dialyzer. The blood is filtered through a semipermeable membrane within the dialyzer, allowing waste and excess substances to pass out of the blood and into a dialysate solution. The filtered blood is then returned to the patient's body. Hemodialysis sessions typically last several hours and are generally performed multiple times a week. The frequency and duration depend on the patient's specific medical condition and the advice of their healthcare provider. It plays a crucial role in maintaining the body's balance of fluids and electrolytes, effectively managing blood pressure, and preventing the accumulation of harmful waste products that would otherwise lead to serious health complications. While it is a demanding and often lifelong treatment, hemodialysis significantly enhances the quality of life and longevity of individuals with kidney failure.

The global market is majorly driven by the increasing incidence of chronic kidney diseases. In line with this, the rising aging population is more susceptible to kidney-related issues, leading to a higher need for hemodialysis. Furthermore, the global diabetes epidemic contributes significantly to kidney disease cases, necessitating hemodialysis. Apart from this, obesity-related kidney diseases fuel the demand for hemodialysis treatments. Moreover, better access to medical facilities has led to increased diagnosis and treatment of kidney diseases. Technological innovations in dialysis machines and procedures improve treatment efficiency. Besides, the escalating awareness about kidney health encourages early intervention and dialysis. Additionally, favorable reimbursement policies enable patients to afford hemodialysis treatments.

Hemodialysis Market Trends/Drivers:

Increasing medical tourism

The growing trend of medical tourism is stimulating the market. Countries with advanced healthcare facilities and lower treatment costs attract patients seeking high-quality hemodialysis services. Medical tourists often choose regions where they can access specialized care, including hemodialysis, at a fraction of the cost they would incur in their home countries. This influx of international patients necessitates the establishment of well-equipped dialysis centers to cater to their needs. Healthcare providers in medical tourism hubs expand their dialysis capacities, employ skilled professionals, and adopt advanced technologies to accommodate the rising demand. As medical tourism continues to rise, the market experiences growth due to the increased volume of patients seeking treatment away from home.

Expansion of dialysis centers worldwide

The global expansion of dialysis centers is pivotal in propelling the market. With more dialysis facilities being established across different regions, access to hemodialysis treatments becomes more widespread. These centers ensure patients with kidney diseases have convenient and timely access to life-sustaining hemodialysis procedures. The expanded network of dialysis centers not only accommodates the growing patient population and facilitates early diagnosis and intervention. This expansion drives market growth by creating a more accessible and patient-centered environment for individuals needing regular hemodialysis sessions. Furthermore, the presence of a broader range of dialysis centers fosters competition, which, in turn, encourages technological advancements and service improvements, enhancing the overall quality of care provided and fueling the demand for hemodialysis services.

Shortage of nephrologists

The shortage of nephrologists is bolstering the market. With fewer nephrologists available to manage the increasing number of kidney disease cases, the demand for hemodialysis services increases. To address this scarcity, healthcare providers expand their hemodialysis offerings, opening new centers and increasing treatment capacities. This phenomenon also encourages the development and implementation of telemedicine solutions, enabling remote consultations and monitoring of hemodialysis patients. Additionally, the shortage prompts healthcare institutions to invest in training and upskilling programs for medical professionals to address the gap in nephrology care. This collaborative effort to cope with the nephrologist shortage results in the wider availability of hemodialysis treatments, ultimately driving the market's growth as more patients rely on these services to manage their kidney health effectively.

Hemodialysis Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global hemodialysis market report, along with forecasts at the global and regional levels from 2024-2032. Our report has categorized the market based on segment, modality, and end-user.

Breakup by Segment:

Hemodialysis Product

Machines

Dialyzers

Others

Hemodialysis Service

In-center Services

Home Services

Hemodialysis service dominates the market

The report has provided a detailed breakup and analysis of the market based on the segment. This includes hemodialysis product (machines, dialyzers, and others) and hemodialysis service (in-center services and home services). According to the report, hemodialysis service represented the largest segment.

The hemodialysis service segment is bolstering the market due to its essential role in delivering life-sustaining treatments to individuals with kidney diseases. As the prevalence of kidney-related conditions rises, the demand for hemodialysis services escalates. These services encompass a comprehensive range of treatments, including pre-dialysis assessments, dialysis sessions, post-treatment care, and patient education. The convenience of receiving expert care within specialized centers or even through home-based setups attracts patients seeking efficient and regular hemodialysis.

Moreover, the adoption of advanced technologies and personalized treatment plans within hemodialysis services enhances treatment effectiveness and patient outcomes. As healthcare providers continue to invest in expanding and refining their hemodialysis service offerings, the segment significantly contributes to market growth by ensuring accessible, quality care for patients dependent on these life-saving procedures.

Breakup by Modality:

Conventional Hemodialysis

Short Daily Hemodialysis

Nocturnal Hemodialysis

Conventional hemodialysis dominates the market

The report has provided a detailed breakup and analysis of the market based on the modality. This includes conventional hemodialysis, short daily hemodialysis, and nocturnal hemodialysis. According to the report, conventional hemodialysis represented the largest segment.

The conventional hemodialysis modality drives market growth due to its widespread adoption and established efficacy in treating kidney diseases. This modality involves using a dialysis machine to filter and cleanse the blood, removing waste and excess fluids. Its long-standing presence and familiarity in medical practice make it a preferred choice for patients and healthcare providers. As the prevalence of kidney diseases increases, the demand for effective treatment options escalates, leading to the continued prominence of conventional hemodialysis.

Additionally, technological advancements have improved dialysis machine efficiency, safety, and patient comfort. These enhancements further bolster the appeal of conventional hemodialysis as a reliable and proven method for managing kidney-related conditions, thereby contributing significantly to the market's overall growth.

Breakup by End-User:

Hospitals

Independent Dialysis Centres

Others

The report has provided a detailed breakup and analysis of the market based on the end-user. This includes hospitals, independent dialysis centres, and others.

Hospitals with advanced medical infrastructure and expert staff provide comprehensive hemodialysis services to multiple patients. Their ability to handle complex cases, offer integrated care, and provide emergency services contributes to the market's expansion.

On the other hand, independent dialysis centers offer specialized care focused solely on hemodialysis. These centers promote convenience and tailored treatment plans, catering to the specific needs of patients. Their growth stems from increased patient preference for outpatient care, flexibility, and proximity to home.

Both segments foster competition, encouraging advancements in treatment quality, technology, and patient experience. As demand for hemodialysis rises, the combined efforts of hospitals and independent centers ensure broader access to life-sustaining treatments, propelling the market forward and meeting the diverse needs of individuals with kidney diseases.

Breakup by Region:

Asia Pacific

Europe

North America

Middle East and Africa

Latin America

North America exhibits a clear dominance, accounting for the largest hemodialysis market share

The report has also provided a comprehensive analysis of all the major regional markets, which include Asia Pacific, Europe, North America, Middle East and Africa, and Latin America. According to the report, North America was the largest market for hemodialysis.

The North American region is a significant driver of market growth due to its advanced healthcare infrastructure, increasing prevalence of kidney diseases, and heightened awareness about renal health. Well-established medical facilities and technological advancements enable the delivery of high-quality hemodialysis services. A rising aging population and lifestyle-related factors contribute to the growing incidence of kidney diseases, thereby propelling the demand for effective treatments like hemodialysis.

Moreover, North America's proactive healthcare policies and reimbursement systems facilitate patient access to these vital procedures. The region's emphasis on research and development leads to continuous improvements in hemodialysis techniques, equipment, and patient care. The partnership between healthcare institutions and industry players further accelerates innovation. The region's robust healthcare ecosystem, coupled with increasing patient needs, ensures the steady expansion of the market.

Competitive Landscape:

Top companies are strengthening the market through innovative products, strategic expansions, and commitment to improving patient outcomes. These companies invest in research and development, continuously introducing advanced dialysis machines, equipment, and solutions that enhance treatment effectiveness and patient comfort. Their focus on technological innovation, such as improved filtration systems and connectivity features, raises the quality of care. Moreover, these companies engage in strategic partnerships and acquisitions, expanding their global reach and enhancing their service portfolios. By collaborating with healthcare institutions and professionals, they facilitate the establishment of specialized dialysis centers and enable easier access to treatments. Additionally, top companies prioritize patient education and support, offering training programs and resources to medical staff and patients. This approach fosters awareness, adherence, and better management of kidney-related conditions, ultimately driving sustained market growth.

The report has provided a comprehensive analysis of the competitive landscape in the hemodialysis market. Detailed profiles of all major companies have also been provided.

Baxter International

Asahi Kasei Corporation

B. Barun Melsungen

DaVita

Cantel Medical Corporation

Fresenius Medical Care

Nipro Corporation

Rockwell Medical

Medivators

Toray Medical Company Ltd.

Nikkiso Co. Ltd.

Surni Group

Gambro

Satellite Healthcare Inc.

Renacon Pharma Ltd.

Recent Developments:

In 2020, Fresenius Medical Care expanded its home dialysis offerings, emphasizing the importance of home-based treatments during the COVID-19 pandemic. They also announced collaborations to enhance remote patient monitoring and telehealth services.

In 2020, Baxter introduced the SHARESOURCE 2 telehealth platform for Peritoneal Dialysis (PD) patients, enhancing remote patient management and communication between patients and healthcare providers.

In 2020, Asahi Kasei announced a partnership with BioPorto to distribute the NGAL Test, a diagnostic tool for the early detection of acute kidney injury, helping better patient management.

Key Questions Answered in This Report

• 1. How big is the global hemodialysis market?
• 2. What is the expected growth rate of the global hemodialysis market during 2024-2032?
• 3. What are the key factors driving the global hemodialysis market?
• 4. What has been the impact of COVID-19 on the global hemodialysis market?
• 5. What is the breakup of the global hemodialysis market based on the segment?
• 6. What is the breakup of the global hemodialysis market based on the modality?
• 7. What are the key regions in the global hemodialysis market?
• 8. Who are the key players/companies in the global hemodialysis market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Hemodialysis Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Breakup by Segment
  • 5.4.1 Market Breakup by Product
  • 5.4.2 Market Breakup by Service
• 5.5 Market Breakup by Modality
• 5.6 Market Breakup by End-User
• 5.7 Market Breakup by Region
• 5.8 Market Forecast

6 Market Breakup by Segment

• 6.1 Hemodialysis Product
  • 6.1.1 Market Trends
  • 6.1.2 Market Breakup by Product
    • 6.1.2.1 Machines
    • 6.1.2.2 Dialyzers
    • 6.1.2.3 Others
  • 6.1.3 Market Forecast
• 6.2 Hemodialysis Service
  • 6.2.1 Market Trends
  • 6.2.2 Market Breakup by Service
    • 6.2.2.1 In-center Services
    • 6.2.2.2 Home Services
  • 6.2.3 Market Forecast

7 Market Breakup by Modality

• 7.1 Conventional Hemodialysis
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Short Daily Hemodialysis
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast
• 7.3 Nocturnal Hemodialysis
  • 7.3.1 Market Trends
  • 7.3.2 Market Forecast

8 Market Breakup by End-User

• 8.1 Hospitals
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 Independent Dialysis Centres
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast
• 8.3 Others
  • 8.3.1 Market Trends
  • 8.3.2 Market Forecast

9 Market Breakup by Region

• 9.1 Asia Pacific
  • 9.1.1 Market Trends
  • 9.1.2 Market Forecast
• 9.2 Europe
  • 9.2.1 Market Trends
  • 9.2.2 Market Forecast
• 9.3 North America
  • 9.3.1 Market Trends
  • 9.3.2 Market Forecast
• 9.4 Middle East and Africa
  • 9.4.1 Market Trends
  • 9.4.2 Market Forecast
• 9.5 Latin America
  • 9.5.1 Market Trends
  • 9.5.2 Market Forecast

10 SWOT Analysis

• 10.1 Overview
• 10.2 Strengths
• 10.3 Weaknesses
• 10.4 Opportunities
• 10.5 Threats

11 Value Chain Analysis

12 Porter's Five Forces Analysis

• 12.1 Overview
• 12.2 Bargaining Power of Buyers
• 12.3 Bargaining Power of Suppliers
• 12.4 Degree of Competition
• 12.5 Threat of New Entrants
• 12.6 Threat of Substitutes

13 Competitive Landscape

• 13.1 Market Structure
• 13.2 Key Players
• 13.3 Profiles of Key Players
  • 13.3.1 Baxter International
  • 13.3.2 Asahi Kasei Corporation
  • 13.3.3 B. Barun Melsungen
  • 13.3.4 DaVita
  • 13.3.5 Cantel Medical Corporation
  • 13.3.6 Fresenius Medical Care
  • 13.3.7 Nipro Corporation
  • 13.3.8 Rockwell Medical
  • 13.3.9 Medivators
  • 13.3.10 Toray Medical Company Ltd.
  • 13.3.11 Nikkiso Co. Ltd.
  • 13.3.12 Surni Group
  • 13.3.13 Gambro
  • 13.3.14 Satellite Healthcare Inc.
  • 13.3.15 Renacon Pharma Ltd.